Partially — 1 of 3 ingredients has pharmacogenetic evidence.
Relevant genes: CYP1A2
Used for: Headaches, migraine, minor aches and painsExcedrin combines three active ingredients: acetaminophen, aspirin, and caffeine. One of them, caffeine, has an established pharmacogenetic relationship with the CYP1A2 gene. That matters more than it sounds. Caffeine isn't in Excedrin just for a pick-me-up. It meaningfully potentiates the analgesic effect of the acetaminophen and aspirin components, and it narrows blood vessels in the brain (part of why the Excedrin Migraine formulation works at all). If your body clears caffeine unusually fast or slow because of your CYP1A2 variant, the duration and strength of relief you get from Excedrin can drift away from what the label promises.
Acetaminophen is cleared primarily by UGT and sulfate conjugation pathways, not by the major CYP enzymes that have the strongest pharmacogenetic evidence. There is ongoing research into UGT1A1 and UGT1A6 variants and how they affect acetaminophen clearance, but no clinically actionable guideline currently applies. Response to acetaminophen is mostly driven by factors other than genetics.
Aspirin (acetylsalicylic acid) is deacetylated rapidly by esterases that aren't known to vary meaningfully between people. Some research has examined cyclooxygenase-1 (COX-1) variants that affect platelet response to aspirin, but these are clinically relevant for cardiovascular prevention, not for the low doses used in an analgesic combination like Excedrin.
Caffeine is cleared almost entirely by the CYP1A2 enzyme. Your CYP1A2 variant decides whether you're a rapid, normal, or slower-than-average metabolizer. Rapid metabolizers clear caffeine in as little as 2 to 3 hours, meaning the boost to acetaminophen and aspirin's analgesic effect fades well before the other ingredients wear off. Slower metabolizers may feel caffeine's effect for 8 hours or more, which can be useful for sustained headache coverage but unhelpful if you're taking Excedrin late in the day.
Read the full caffeine genetics guide →Published guidance from Gene2Rx on how caffeine should be dosed or substituted based on your CYP1A2 phenotype.
| Phenotype | What it means | Recommendation | Evidence |
|---|---|---|---|
|
Ultrarapid Metabolizer
CYP1A2
|
You clear caffeine very quickly, so you may need more or more frequent servings to feel its effects. |
Gene2Rx
Caffeine is cleared very quickly, which may reduce its stimulant effect. You may require larger or more frequent servings to achieve your desired level of stimulation. Monitor your intake to avoid excessive consumption.
|
Moderate |
|
Rapid Metabolizer
CYP1A2
|
You clear caffeine quickly, so you might drink more coffee to feel its effects. |
Gene2Rx
You clear caffeine faster than average, which may shorten its duration of action. You may need more frequent servings to maintain the desired effect. Space your servings to prevent withdrawal symptoms.
|
Moderate |
|
Normal Metabolizer
CYP1A2
|
You clear caffeine at a normal rate; usual intake guidelines apply. |
Gene2Rx
Follow standard moderate intake guidelines (≤400 mg/day).
|
— |
|
Intermediate Metabolizer
CYP1A2
|
You clear caffeine more slowly, so effects last longer—avoid drinking coffee late in the day. |
Gene2Rx
Standard advice on moderate caffeine intake; consider avoiding late-day caffeine to prevent sleep disturbances.
|
— |
|
Slow Metabolizer
CYP1A2
|
You clear caffeine slowly, so it stays in your system longer—consider drinking less coffee to avoid jitters or poor sleep. |
Gene2Rx
Recommend reduced intake (e.g. ≤100 mg/day) and longer intervals between doses to avoid adverse effects.
|
Moderate |
|
Indeterminate
CYP1A2
|
We don’t know how your genetics affect caffeine metabolism. |
Gene2Rx
Follow general caffeine guidelines and monitor personal tolerance.
|
— |
|
Not available
CYP1A2
|
We don’t know how your genetics affect caffeine metabolism. |
Gene2Rx
Follow general caffeine guidelines and monitor personal tolerance.
|
— |
Source: Gene2Rx
CYP1A2 is the liver enzyme that clears caffeine, clozapine, and a handful of other drugs. Its activity is shaped by both genetics and lifestyle (smoking speeds it up, certain foods slow it down), but the underlying gene still sets your baseline. About 40 percent of people carry a variant that classifies them as rapid metabolizers; the rest process caffeine at an average or slower rate.
Rapid metabolizers clear caffeine quickly and may feel less effect from a given dose. Slower metabolizers feel caffeine longer and at lower doses.
If Excedrin works reliably for you, nothing about your genetics changes that advice. But if you find Excedrin unreliable, sometimes effective and sometimes not, or wearing off faster than the package suggests, a CYP1A2 variant is a real candidate for why. Rapid metabolizers may need to retime the dose or consider formulations where caffeine isn't doing the lifting (plain acetaminophen plus a separate caffeine source, dosed to their metabolism).
Yes. The FDA approved Excedrin Migraine specifically because the acetaminophen plus aspirin plus caffeine combination was shown to be more effective for migraine than the analgesics alone. The caffeine isn't cosmetic. It's load-bearing, which is why how quickly you metabolize caffeine genuinely changes how Excedrin feels.
The active ingredients are the same: acetaminophen, aspirin, and caffeine. The pharmacogenetics are identical. The differences are in how the product is marketed and what label indications are included.
A pharmacogenetic report will tell you your CYP1A2 metabolizer status, which is the best genetic predictor of how caffeine will behave in your body. It can't guarantee whether Excedrin will work for a given headache, because headache response is multifactorial, but it can explain a pattern if your response to caffeine-containing products feels inconsistent.
This page describes the general pharmacogenetics. A Gene2Rx report analyzes your own DNA to tell you which metabolizer group you fall into, across every medication.
Get your report Look up another medicationInformational only — not medical advice. Pharmacogenetic guidance describes population-level patterns; your individual response depends on many factors. Never start, stop, or change a medication without talking to your prescribing clinician.